Vemurafenib in melanoma with BRAF V600E mutation

N Engl J Med. 2011 Oct 13;365(15):1448-9; author reply 1450. doi: 10.1056/NEJMc1108651.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Dacarbazine / therapeutic use*
  • Female
  • Humans
  • Indoles / therapeutic use*
  • Male
  • Melanoma / drug therapy*
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
  • Sulfonamides / therapeutic use*

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Dacarbazine
  • Proto-Oncogene Proteins B-raf